S. 1095
This bill makes it an unfair method of competition to submit an objectively baseless petition to the Food and Drug Administration (FDA) in an attempt to interfere with a competitor's application for market approval of a drug.
Learn about this bill’s status and read its full summary in the Pocket Congress app.
Scan to open this page in Pocket Congress